Clincosm LogoSign in Get a demo

Non-alcoholic Steatohepatitis (NASH)

Showing 1 - 25 of 34
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-alcoholic Steatohepatitis (NASH) Trial in Austria, Germany, Sweden (AZD9550, Placebo)

Recruiting
  • Non-alcoholic Steatohepatitis (NASH)
  • Graz, Austria
  • +4 more
Nov 21, 2023

Non-Alcoholic Steatohepatitis (NASH) Trial in Fort Myers, Sarasota (Pemvidutide, Placebo)

Recruiting
  • Non-Alcoholic Steatohepatitis (NASH)
  • Fort Myers, Florida
  • +1 more
Aug 10, 2023

Non-alcoholic Steatohepatitis (NASH) Trial in Berlin (NNC0194-0499)

Not yet recruiting
  • Non-alcoholic Steatohepatitis (NASH)
  • Berlin, Germany
    Novo Nordisk Investigational Site
Feb 17, 2023

Antipsychotic Induced Weight Gain, Non-alcoholic Steatohepatitis (NASH) Trial in Miami (Miricorilant, Fluvoxamine)

Recruiting
  • Antipsychotic Induced Weight Gain
  • Non-alcoholic Steatohepatitis (NASH)
  • Miami, Florida
    Site 01
Feb 3, 2023

Non-Alcoholic Fatty Liver Disease (NAFLD), Non-Alcoholic Steatohepatitis (NASH), Liver Fibroses Trial in Boston (Liver Incytes

Active, not recruiting
  • Non-Alcoholic Fatty Liver Disease (NAFLD)
  • +3 more
  • Liver Incytes System
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Centre
Dec 7, 2022

Non-alcoholic Steatohepatitis (NASH) Trial in Miami Lakes, Miami (Miricorilant)

Recruiting
  • Non-alcoholic Steatohepatitis (NASH)
  • Miami Lakes, Florida
  • +1 more
Nov 2, 2022

Non-alcoholic Steatohepatitis (NASH) Trial in Las Vegas (ECC4703, Placebo)

Recruiting
  • Non-alcoholic Steatohepatitis (NASH)
  • Las Vegas, Nevada
    Eccogene Investigational Site
Sep 20, 2022

Non-alcoholic Steatohepatitis (NASH) Trial in Worldwide (No Intervention)

Recruiting
  • Non-alcoholic Steatohepatitis (NASH)
  • No Intervention
  • Coronado, California
  • +47 more
Aug 16, 2022

Non-alcoholic Steatohepatitis (NASH), Endoscopic Sleeve Gastroplasty, Non-alcoholic Fatty Liver Disease (NAFLD) Trial in Boston

Recruiting
  • Non-alcoholic Steatohepatitis (NASH)
  • +6 more
  • Insulin Resistance
  • +4 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 19, 2022

Non-alcoholic Steatohepatitis (NASH) Trial in Brooklyn (AZD4076, Placebo)

Completed
  • Non-alcoholic Steatohepatitis (NASH)
  • Brooklyn, Maryland
    Research Site
Jun 14, 2022

Liver Fat Content, Fatty Acid Composition, and Fibrosis Using

Not yet recruiting
  • Non-alcoholic Fatty Liver Disease (NAFLD)
  • Non-alcoholic Steatohepatitis (NASH)
    • Hong Kong, Shatin, Hong Kong
      The Chinese University of Hong Kong, Prince of Wale Hospital
    May 19, 2022

    Non-alcoholic Steatohepatitis (NASH) Trial in Worldwide (Tropifexor (LJN452), Cenicriviroc (CVC))

    Completed
    Has Results
    • Non-alcoholic Steatohepatitis (NASH)
    • Tropifexor (LJN452)
    • Cenicriviroc (CVC)
    • Chandler, Arizona
    • +64 more
    Apr 27, 2022

    Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) Trial in Charlottesville (AZ compound, Placebo)

    Terminated
    Has Results
    • Non-alcoholic Fatty Liver Disease (NAFLD)
    • Non-alcoholic Steatohepatitis (NASH)
    • AZ compound
    • Placebo
    • Charlottesville, Virginia
      Yogesh Yadav
    Mar 10, 2022

    Type 2 Diabetes, Non-alcoholic Steatohepatitis (NASH), Non-alcoholic Fatty Liver Disease (NAFLD) Trial in Germany (Empagliflozin

    Recruiting
    • Type 2 Diabetes
    • +2 more
    • Empagliflozin 10mg oral tablet / Semaglutide 1mg pen injector
    • +2 more
    • Duesseldorf, Nordrhein-Westfalen, Germany
    • +29 more
    Jan 5, 2022

    Non Alcoholic Fatty Liver Disease and Predictors of Advanced

    Withdrawn
    • Non-alcoholic Steatohepatitis (NASH)
    • CT imaging
    • Irving, Texas
      The Liver Institute at Methodist Dallas Medical Center
    Dec 9, 2021

    Non-Alcoholic Steatohepatitis (NASH) Trial in Changchun (ZSP1601, ZSP1601 Placebo)

    Completed
    • Non-Alcoholic Steatohepatitis (NASH)
    • Changchun, Jilin, China
      The First Hospital of Jilin University
    Oct 8, 2021

    Non-Alcoholic Steatohepatitis (NASH), Type2 Diabetes Trial in Jerusalem (Oral Insulin)

    Completed
    Has Results
    • Non-Alcoholic Steatohepatitis (NASH)
    • Type2 Diabetes Mellitus
    • Oral Insulin
    • Jerusalem, Israel
      Hadassah Medical Center
    Aug 27, 2021

    Non-alcoholic Steatohepatitis (NASH) Trial in Worldwide (Tropifexor (LJN452), Placebo)

    Terminated
    Has Results
    • Non-alcoholic Steatohepatitis (NASH)
    • Tropifexor (LJN452)
    • Placebo
    • Madison, Alabama
    • +80 more
    Aug 11, 2021

    Longitudinal Observational Study Of Chinese With NAFLD/NASH

    Recruiting
    • Non-Alcoholic Fatty Liver Disease (NAFLD)
    • Non-Alcoholic Steatohepatitis (NASH)
      • Hong Kong, Hong Kong
        Humanity and Health Medical Centre
      Aug 27, 2021

      Non-Alcoholic Steatohepatitis (NASH) Trial in Worldwide (IVA337, Placebo)

      Completed
      Has Results
      • Non-Alcoholic Steatohepatitis (NASH)
      • Madison, Alabama
      • +84 more
      Mar 16, 2021

      Non-Alcoholic Steatohepatitis (NASH) Trial in Secaucus (HPN-01, Placebo)

      Recruiting
      • Non-Alcoholic Steatohepatitis (NASH)
      • Secaucus, New Jersey
        Frontage Clinical Services, Inc
      Feb 8, 2021

      Non-alcoholic Steatohepatitis (NASH) Trial (GB1211, Placebo)

      Withdrawn
      • Non-alcoholic Steatohepatitis (NASH)
      • (no location specified)
      Feb 2, 2021

      Gut Microbiota and Modulation of Liver Damage in NAFLD

      Completed
      • Simple Steatosis (SS)
      • +2 more
      • liver and white adipose tissue biopsies
      • Rome, Italy
        Stefano Ginanni Corradini
      Nov 19, 2020

      Non-alcoholic Steatohepatitis (NASH) Trial in Santander (Endoscopic Sleeve Gastroplasty (ESG) with OverStitch® system +

      Recruiting
      • Non-alcoholic Steatohepatitis (NASH)
      • Endoscopic Sleeve Gastroplasty (ESG) with OverStitch® system + Lifestyle modifications
      • Laparoscopic Sleeve Gastrectomy (LSG) + Lifestyle modifications
      • Santander, Cantabria, Spain
        Hospitl Universitario Marqués de Valdecilla
      Sep 28, 2020

      Non-alcoholic Steatohepatitis (NASH) Trial in Jerusalem, Nazareth, Petach Tikva (CF102, Placebo)

      Completed
      • Non-alcoholic Steatohepatitis (NASH)
      • Jerusalem, Israel
      • +2 more
      Mar 16, 2020